These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 22943085)
1. Late onset laryngeal stenosis following radiotherapy for head and neck carcinoma: a case series. Jayawardena J; O'Connor TE; White R; Chai F ANZ J Surg; 2012 Sep; 82(9):657-8. PubMed ID: 22943085 [No Abstract] [Full Text] [Related]
3. Unexpected radiation laryngeal necrosis after carbon ion therapy using conventional dose fractionation for laryngeal cancer. Demizu Y; Fujii O; Nagano F; Terashima K; Jin D; Mima M; Oda N; Takeuchi K; Takeda M; Ito K; Fuwa N; Okimoto T Jpn J Clin Oncol; 2015 Nov; 45(11):1076-81. PubMed ID: 26355161 [TBL] [Abstract][Full Text] [Related]
4. Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy. Caglar HB; Tishler RB; Othus M; Burke E; Li Y; Goguen L; Wirth LJ; Haddad RI; Norris CM; Court LE; Aninno DJ; Posner MR; Allen AM Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1110-8. PubMed ID: 18468812 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of image-guided radiotherapy for laryngeal sparing in head and neck cancer. Nguyen NP; Ceizyk M; Vos P; Vinh-Hung V; Davis R; Desai A; Abraham D; Krafft SP; Jang S; Watchman CJ; Ewell L; Hamilton R; Smith-Raymond L Oral Oncol; 2010 Apr; 46(4):283-6. PubMed ID: 20188620 [TBL] [Abstract][Full Text] [Related]
6. The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck. Daly T; Poulsen MG; Denham JW; Peters LJ; Lamb DS; Krawitz H; Hamilton C; Keller J; Tripcony L; Walker Q Radiother Oncol; 2003 Aug; 68(2):113-22. PubMed ID: 12972305 [TBL] [Abstract][Full Text] [Related]
7. Radiotherapeutic factors affecting the incidence of developing hypothyroidism after radiotherapy for head and neck squamous cell cancer. El-Shebiney M; El-Mashad N; El-Mashad W; El-Ebiary AA; Kotkat AE J Egypt Natl Canc Inst; 2018 Mar; 30(1):33-38. PubMed ID: 29428369 [TBL] [Abstract][Full Text] [Related]
9. [Dysphonia as a symptom of a radiation of the neck]. Reiter R; Pickhard A; Hoffmann TK; Brosch S Laryngorhinootologie; 2014 Dec; 93(12):859-60. PubMed ID: 25098719 [No Abstract] [Full Text] [Related]
10. Analysis of late complications after rapid hyperfractionated radiotherapy in advanced head and neck cancers. Nguyen TD; Panis X; Froissart D; Legros M; Coninx P; Loirette M Int J Radiat Oncol Biol Phys; 1988 Jan; 14(1):23-5. PubMed ID: 3335458 [TBL] [Abstract][Full Text] [Related]
11. The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma. Lyhne NM; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Evensen J; Mortensen HR; Overgaard J Radiother Oncol; 2015 Oct; 117(1):91-8. PubMed ID: 26255764 [TBL] [Abstract][Full Text] [Related]
12. Management of vascular complications of head and neck cancer. Rimmer J; Giddings CE; Vaz F; Brooks J; Hopper C J Laryngol Otol; 2012 Feb; 126(2):111-5. PubMed ID: 21888748 [TBL] [Abstract][Full Text] [Related]
13. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet- and speech-related quality of life. Dornfeld K; Simmons JR; Karnell L; Karnell M; Funk G; Yao M; Wacha J; Zimmerman B; Buatti JM Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):750-7. PubMed ID: 17418971 [TBL] [Abstract][Full Text] [Related]
14. Systematic use of patient reported outcome during radiotherapy for head and neck cancer: study protocol for the national DAHANCA 38 trial. Holländer-Mieritz C; Johansen J; Taarnhøj GA; Johansen C; Vogelius IR; Kristensen CA; Pappot H Acta Oncol; 2020 May; 59(5):603-607. PubMed ID: 32056473 [No Abstract] [Full Text] [Related]
15. Radiolabeled antibody combined with external radiotherapy for the treatment of head and neck cancer: reconstruction of a theoretical phantom of the larynx for radiation dose calculation to local tissues. Maraveyas A; Myers M; Stafford N; Rowlinson-Busza G; Stewart JS; Epenetos AA Cancer Res; 1995 Mar; 55(5):1020-7. PubMed ID: 7866985 [TBL] [Abstract][Full Text] [Related]
16. Dosimetric predictors of dysphonia after intensity-modulated radiotherapy for oropharyngeal carcinoma. Sanguineti G; Ricchetti F; McNutt T; Wu B; Fiorino C Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):32-8. PubMed ID: 23992739 [TBL] [Abstract][Full Text] [Related]
17. NTCP modeling of subacute/late laryngeal edema scored by fiberoptic examination. Rancati T; Fiorino C; Sanguineti G Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):915-23. PubMed ID: 19747783 [TBL] [Abstract][Full Text] [Related]
18. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now! Dubben HH; Beck-Bornholdt HP Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):563. PubMed ID: 11579925 [No Abstract] [Full Text] [Related]
19. Status of accelerated fractionation radiotherapy in head and neck squamous cell carcinomas. Bourhis J; Wibault P; Lusinchi A; Bobin S; Luboinski B; Eschwege F Curr Opin Oncol; 1997 May; 9(3):262-6. PubMed ID: 9229149 [TBL] [Abstract][Full Text] [Related]
20. Development of a standardized method for contouring the larynx and its substructures. Choi M; Refaat T; Lester MS; Bacchus I; Rademaker AW; Mittal BB Radiat Oncol; 2014 Dec; 9():285. PubMed ID: 25499048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]